𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Does prophylactic ursodeoxycholic acid treatment of liver tranplant patients prevent acute rejection?

✍ Scribed by Susanne Keiding

Book ID
102241224
Publisher
John Wiley and Sons
Year
1998
Tongue
English
Weight
19 KB
Volume
27
Category
Article
ISSN
0270-9139

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

A randomized clinical trial of ursodeoxy
A randomized clinical trial of ursodeoxycholic acid as adjuvant treatment to prevent liver transplant rejection
✍ D Barnes; D Talenti; G Cammell; M Goormastic; L Farquhar; M Henderson; D Vogt; J πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 174 KB πŸ‘ 2 views

Acute rejection following orthotopic liver transplantation is a common problem despite current immunosuppressive regimens. Ursodeoxycholic acid (UDCA) has been shown in small, open-labeled studies to prevent rejection episodes, although its effects on complications such as infections, length of hosp

Does antimitochondrial antibody status a
Does antimitochondrial antibody status affect response to treatment in patients with primary biliary cirrhosis? Outcomes of ursodeoxycholic acid therapy and liver transplantation
✍ W R Kim; J J Poterucha; R A Jorgensen; K P Batts; H A Homburger; E R Dickson; R πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 270 KB πŸ‘ 2 views

rum. 1 In the past decade, two treatment modalities have Approximately 5% to 10% of patients with features otherbeen shown to be effective in the treatment for PBC, dewise consistent with primary biliary cirrhosis (PBC) lack antipending on the stage of the disease. For patients with less mitochondri